Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Pfizer stuns Wall Street with booming Q3 earnings and new guidance boost
Pfizer Inc. delivered a financial jolt in its third quarter of 2024, surpassing Wall Street’s expectations and raising…
Hoth Therapeutics shares explode 34% on what could be a life-saving cancer drug
In a significant breakthrough, Hoth Therapeutics Inc., a biopharmaceutical company focused on novel cancer treatments, saw its stock…
AbbVie makes bold move in Alzheimer’s market with $1.4bn Aliada buyout—Is it a gamble?
AbbVie, the renowned American biopharmaceutical giant, is set to acquire Aliada Therapeutics for a staggering $1.4 billion. The…
Evoke Pharma’s stock skyrockets on impressive Gimoti data—what this means for diabetic gastroparesis patients
Shares in Evoke Pharma experienced an extraordinary 70% surge following the release of new, promising data on their…
Kidney disease breakthrough sends Vera Therapeutics shares skyrocketing by 14%
Vera Therapeutics, a biotechnology company based in Brisbane, California, witnessed a 14% surge in its share price following…
Sanjivani Paranteral achieves robust Q2 FY25 growth with 29.5% revenue surge
Sanjivani Paranteral Ltd, a pharmaceutical powerhouse based in Mumbai, has announced remarkable financial results for Q2 of the…
Recce Pharmaceuticals secures phase II trial safety approval for breakthrough R327G treatment
Recce Pharmaceuticals Limited recently announced significant progress in its phase II clinical trial for RECCE 327 Topical Gel…
Bora Pharmaceuticals set to shake up rare disease treatment with Pyros Pharmaceuticals acquisition
Bora Pharmaceuticals Co., Ltd. is intensifying its presence in the rare disease treatment market by acquiring U.S.-based Pyros…
vTv Therapeutics and OnKure part ways, dissolving pivotal cellular drug agreement
vTv Therapeutics, a clinical-stage biopharmaceutical company known for its innovative approach in diabetes treatment, and OnKure Therapeutics, an…
Merck’s $1.3bn bet on cancer therapy: Inside the Modifi Biosciences acquisition
Merck & Co., a global leader in pharmaceuticals, has acquired Modifi Biosciences, a cutting-edge biotech startup based in…